TEVADAPTOR Closed Drug Reconstitution and Transfer System
by Teva Medical Ltd., Migada Plant 3 variants
510(k) K141448
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK141448 | Date23 Jan 2015 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- ONB
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5440
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
The TEVADAPTOR is a Closed System Drug Transfer Device (CSTD) that mechanically prohibits the release of drugs in vapor, aerosol or liquid form during preparation and administration. It prevents the introduction of microbial and airborne contaminants into the drug or fluid path, minimizing exposure of healthcare personnel and the environment to hazardous drugs.
The system is supplied by Teva Medical Ltd., Migada Plant and has received FDA 510(k) clearance with the product code ONB. It is designed for use in general hospital settings for handling antineoplastic and hazardous drugs. The device is classified as a Class II medical device and is intended to provide a closed system for drug reconstitution and transfer procedures.
Other devices from Teva Medical Ltd., Migada Plant
Questions
AI-generated answers, 25 Sep 2026
What is the TEVADAPTOR system designed for?
The TEVADAPTOR is a Closed System Drug Transfer Device (CSTD) designed to mechanically prevent the release of drugs in vapor, aerosol or liquid form during preparation and administration, minimizing exposure to hazardous drugs.
How is the TEVADAPTOR system supplied?
The TEVADAPTOR system is supplied by Teva Medical Ltd., Migada Plant and is designed for use in general hospital settings for handling antineoplastic and hazardous drugs.
What regulatory clearance has the TEVADAPTOR received?
The TEVADAPTOR has received FDA 510(k) clearance with the product code ONB and is classified as a Class II medical device, providing a closed system for drug reconstitution and transfer procedures.
What environments is the TEVADAPTOR intended for?
The TEVADAPTOR is intended for use in general hospital settings for handling antineoplastic and hazardous drugs, designed to prevent the introduction of microbial and airborne contaminants into the drug path.